BioSpace News Archive

Medical preparation derived from plants or natural sources is called botanicals. Botanicals are also called herbal or natural supplements.

TIAN RUIXIANG Holdings Ltd, a China-based insurance broker, announces that it has been commissioned by Zhongkang Yiyang Health Technology Co., Ltd., a company providing technology and health management related services, to develop and launch the “Zhongkang Huimin Cancer Prevention Insurance”, a specialty health insurance product relating to cancer prevention and treatment to be offered to residents in Mainland China.

TCR2 Therapeutics Inc., a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, announced that management will participate at two upcoming conferences in June using a virtual platform.

Tuebingen, Germany and Houston, Texas, May26, 2021 – Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced changes to its Board of Directors.

Evelo Biosciences, a clinical stage biotechnology company developing a new modality of orally delivered medicines, announced that management will present at three upcoming virtual investor conferences in June:

BioCryst Pharmaceuticals, Inc. announced that the company will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 2:30 p.m. ET and the JMP Securities Life Sciences Conference on Thursday, June 17, 2021 at 1:30 p.m. ET.

Life science refers to a branch of science that studies organisms and microorganisms. It is an umbrella term of wide range of fields such as cell biology, biotechnology, genetics, molecular biology, biomedicine, and biochemistry.

The global hypodermic needles market is likely to exhibit robust growth. The increasing prevalence of chronic ailments and a rising geriatric population are the key factors boosting the market.

Chronic lymphocytic leukemia is a common type of leukemia found in adults. In this type of cancer, lymphocytes, i.e., white blood cells develop in the bone marrow and travel through the blood.

Growing use of unique blood biomarkers in the treatment of uveal melanoma fuels the revenue opportunities for the uveal melanoma treatment market